JPH05286863A - Improvement of organic compound - Google Patents
Improvement of organic compoundInfo
- Publication number
- JPH05286863A JPH05286863A JP4065824A JP6582492A JPH05286863A JP H05286863 A JPH05286863 A JP H05286863A JP 4065824 A JP4065824 A JP 4065824A JP 6582492 A JP6582492 A JP 6582492A JP H05286863 A JPH05286863 A JP H05286863A
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- carrot
- rice flour
- drink
- per liter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000006872 improvement Effects 0.000 title description 2
- 150000002894 organic compounds Chemical class 0.000 title 1
- 239000000203 mixture Substances 0.000 claims abstract description 29
- 235000013312 flour Nutrition 0.000 claims abstract description 20
- 244000000626 Daucus carota Species 0.000 claims abstract description 19
- 235000002767 Daucus carota Nutrition 0.000 claims abstract description 19
- 241000209094 Oryza Species 0.000 claims abstract description 18
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 18
- 235000009566 rice Nutrition 0.000 claims abstract description 18
- 239000003792 electrolyte Substances 0.000 claims abstract description 12
- 239000000843 powder Substances 0.000 claims abstract description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 5
- 239000008103 glucose Substances 0.000 claims abstract description 5
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims abstract description 4
- 229920000642 polymer Polymers 0.000 claims abstract description 4
- 208000010444 Acidosis Diseases 0.000 claims abstract description 3
- 206010027417 Metabolic acidosis Diseases 0.000 claims abstract description 3
- 150000001720 carbohydrates Chemical class 0.000 claims description 23
- 235000014633 carbohydrates Nutrition 0.000 claims description 23
- 239000007788 liquid Substances 0.000 claims description 15
- 239000000460 chlorine Substances 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 239000000463 material Substances 0.000 claims 2
- -1 chlorine ions Chemical class 0.000 claims 1
- 150000002500 ions Chemical class 0.000 claims 1
- 229910001415 sodium ion Inorganic materials 0.000 claims 1
- 229920002774 Maltodextrin Polymers 0.000 abstract description 7
- 239000004215 Carbon black (E152) Substances 0.000 abstract 7
- 229930195733 hydrocarbon Natural products 0.000 abstract 7
- 150000002430 hydrocarbons Chemical class 0.000 abstract 7
- 230000035622 drinking Effects 0.000 abstract 1
- 208000005156 Dehydration Diseases 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 230000018044 dehydration Effects 0.000 description 9
- 238000006297 dehydration reaction Methods 0.000 description 9
- 239000011734 sodium Substances 0.000 description 9
- 206010012735 Diarrhoea Diseases 0.000 description 8
- 238000009472 formulation Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000005913 Maltodextrin Substances 0.000 description 5
- 229940035034 maltodextrin Drugs 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 230000004580 weight loss Effects 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000000147 enterotoxin Substances 0.000 description 2
- 231100000655 enterotoxin Toxicity 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 206010012742 Diarrhoea infectious Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241001417093 Moridae Species 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 201000009840 acute diarrhea Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 230000003870 intestinal permeability Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000005135 methemoglobinemia Diseases 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000032724 odontogenesis Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- KVMLCRQYXDYXDX-UHFFFAOYSA-M potassium;chloride;hydrochloride Chemical compound Cl.[Cl-].[K+] KVMLCRQYXDYXDX-UHFFFAOYSA-M 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 206010040560 shock Diseases 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】この発明は、経口用再水和製剤に
関するものである。TECHNICAL FIELD The present invention relates to an oral rehydration preparation.
【0002】[0002]
【従来の技術】最近の数十年間に、下痢による世界の幼
児死亡率は著しく減少してはいるが、下痢は依然として
健康上重要な問題である。下痢は、通常胃腸管からの液
体および電解質の過剰損失と定義される。これは、2つ
の腸管機能である吸収と分泌の平衡が破れたときに起
る。病態生理学的には、3つの型の感染性下痢がある。
すなわち、下痢は、ウイルス性であるか、またはエンテ
ロトキシン(腸管毒)によるかもしくは腸粘膜に対する微
生物の侵入によるものであり得る。急性の下痢の処置に
おいては次の問題を解決しなければならない。 1)水の分泌過剰および/または水の吸収減少による脱
水。 2)栄養の腸管吸収不全。 3)腸管透過性の増大およびそれによる蛋白質の粘膜通
過のおそれとアレルギー出現のおそれ。 4)粘膜および蛋白質のそう失を伴なう腸管滲出。 これらの問題全部の中で、最も急いで解決する必要があ
るのは脱水のおそれである。再水和の必要量は下痢の病
因にも患者の年令にもよらず、患者の脱水度によるが、
これは体重の減少により容易に測定できる。それぞれの
状況に特に応じた経口用再水和製剤の使用は、下痢並び
に病気の熱、発汗の増加、日光または熱環境への高度ば
く露、(乳児の)強い活動、歯の発生による唾液分泌増
加、および(成人の)高度液体そう失を伴なう作業のよう
な他の原因による脱水の予防および治療の両者に適して
いる。BACKGROUND OF THE INVENTION Although the world infant mortality rate due to diarrhea has decreased remarkably over the last few decades, diarrhea remains a significant health problem. Diarrhea is usually defined as an excess loss of fluid and electrolytes from the gastrointestinal tract. This occurs when the balance between absorption and secretion, two intestinal functions, is broken. There are three types of infectious diarrhea pathophysiologically.
That is, the diarrhea can be viral or due to enterotoxins (enterotoxins) or due to microbial invasion of the intestinal mucosa. The following problems must be solved in the treatment of acute diarrhea. 1) Dehydration due to oversecretion of water and / or reduced absorption of water. 2) Insufficiency of intestinal absorption of nutrition. 3) Increased intestinal permeability, resulting in the possibility of protein passage through the mucous membrane and the appearance of allergies. 4) Intestinal effusion with mucosal and protein loss. Of all these problems, the most urgent need to resolve is the risk of dehydration. The rehydration requirement depends on the patient's dehydration, not on the etiology of diarrhea or the patient's age.
This can be easily measured by weight loss. The use of oral rehydration formulations specifically tailored to each situation includes diarrhea and illness fever, increased sweating, high exposure to the sun or thermal environment, strong (infant) activity, salivation due to tooth development. It is suitable for both prevention and treatment of dehydration due to other causes, such as increased and work with (adult) high fluid loss.
【0003】この発明によると、特に効果的な患者の再
水和を、慣用(conventional)炭水化物、米粉(rice flo
ur)およびにんじんの粉(carrot powder)を炭水化物源
として含む飲料(drink)を患者に経口投与することによ
り達成し得ることが見出された。すなわち、この発明
は、そう失Na+およびK+電解質を補うに充分な量の上
記電解質と共に、炭水化物源として慣用炭水化物、米粉
およびにんじんの粉を含む、経口用再水和製剤を提供す
るものである。この発明による経口用再水和製剤は、幼
児および成人に使用し得るのはいうまでもないが、特に
離乳していない幼児に適する。According to the invention, a particularly effective rehydration of the patient is achieved by using conventional carbohydrate, rice flour (rice flo).
It has been found that this can be achieved by orally administering to the patient a drink containing ur) and carrot powder as a carbohydrate source. That is, the present invention provides an oral rehydration preparation containing conventional carbohydrates, rice flour and carrot flour as a carbohydrate source, together with a sufficient amount of the above electrolytes to supplement the Na + and K + electrolytes. is there. Needless to say, the oral rehydration preparation according to the present invention can be used for infants and adults, but it is particularly suitable for infants who have not been weaned.
【0004】米粉は、前糊化(pregelatinised)形のもの
が好便に使用される。にんじんは凍結乾燥して粉末形態
したものが好便である。にんじんに基づく市販製品の使
用は、(反応して硝酸塩になる)亜硝酸塩の濃度の制御を
可能にし、この食物に基づく家庭製品を小さな乳児(4
か月未満の乳児)に使用したときにみられるメトヘモグ
ロビン血症の危険性を回避する。経口用再水和製剤の亜
硝酸レベルは製品100g当り4mg未満とするのが好適
である。米粉:にんじん(好ましくは粉末形)の重量比は
広い範囲、例えば5:1−1:5の間で変り得る。炭水化
物源として米粉とにんじんの粉を用いると、直ちに使用
できる飲料の場合、水に溶解後に浸透圧を大きく増加す
ることなく、慣用炭水化物のみによるより高い炭水化物
供給が可能になる。にんじんの粉は製品のフレーバーを
よくし、味が苦いことが知られているカリウムの存在に
も拘らず添加物(甘味剤)の使用を不要にする。本明細書
にいう慣用炭水化物の語は、グルコースポリマー類また
はマルトデキストリン類、例えばマルトデキストリンD
E25のような、経口用再水和製剤に使用するに適する
ことが知られている炭水化物に関して用いる。The rice flour is preferably in a pregelatinized form. The carrot is conveniently lyophilized and in powder form. The use of commercial products based on carrot allows control of the concentration of nitrite (which reacts to nitrates), making this food-based household product a small infant (4
Avoid the risk of methemoglobinemia seen when used in infants <months of age). It is preferred that the oral rehydrated formulation have a nitrite level of less than 4 mg per 100 g of product. The rice flour: carrot (preferably powdered) weight ratio can vary over a wide range, for example between 5: 1 and 1: 5. The use of rice flour and carrot flour as the carbohydrate source allows a higher carbohydrate supply with conventional carbohydrates alone, without significantly increasing the osmotic pressure after dissolution in water for ready-to-use beverages. Carrot flour enhances the flavor of the product and obviates the use of additives (sweeteners) despite the presence of potassium, which is known to be bitter in taste. The term conventional carbohydrate as used herein refers to glucose polymers or maltodextrins, such as maltodextrin D.
Used with respect to carbohydrates known to be suitable for use in oral rehydration formulations, such as E25.
【0005】米粉とにんじんに由来する炭水化物対慣用
炭水化物の重量比は広範に変化し得るが、ドリンク(飲
料)液が僅かに高張でドリンクの味が快いように選択す
るのが好適である。一般に、このような結果は、米粉と
にんじんに由来する炭水化物:慣用炭水化物の重量比を
1:1−1:7に、好ましくは1:2−1:5、例えば1:
4の範囲で用いたとき得られる。再水和製剤の組成は、
ドリンク液の形にしたとき僅かに高張になるように選択
するのが好適である。したがって、ドリンクの浸透圧重
量モル濃度はドリンク液1kg当り300ミリオスモル未
満が好ましい。それ故、ドリンクの浸透圧モル濃度は2
10−290、例えば250ミリオスモル/ドリンク液
リットルが好適である。Although the weight ratio of carbohydrates derived from rice flour and carrot to conventional carbohydrates can vary widely, it is preferred that the drink (beverage) liquor be selected to be slightly hypertonic and pleasant to drink. Generally, such results indicate that the weight ratio of carbohydrates derived from rice flour and carrot: conventional carbohydrates is 1: 1-1: 7, preferably 1: 2-1: 5, for example 1: 2.
Obtained when used in the range of 4. The composition of the rehydrated formulation is
It is preferred to choose to be slightly hypertonic when in the form of a drink. Therefore, the osmolality of the drink is preferably less than 300 milliosmol per kg of the liquid drink. Therefore, the osmolarity of the drink is 2
Preference is given to 10-290, for example 250 mOsmol / l of liquid drink.
【0006】使用する炭水化物源の量とタイプは、ドリ
ンク液1リットルが30−90g、好ましくは50−7
0g、例えば60gの炭水化物/lを供給するように選択
するのが好適である。Na+およびK+電解質に加えて、
経口再水和組成物は代謝性アシドーシスを補正するため
に塩基を含有するのが好適である。この目的に適する塩
基は、重炭酸塩、さらに適当には例えばくえん酸3ナト
リウム2水和物の形のくえん酸塩である。添加する電解
質と塩基の量は、ドリンク液にしたとき適当な濃度が得
られるように選択するのが好適である。Na+の場合、こ
の濃度はドリンク液1リットル当り30−90ミリ当量
の範囲が好適である。一般に、低濃度、例えば50−7
0ミリ当量/lを供給することが指示されるが、コレラ
のような高度のNa損失が起る疾病の場合には高濃度の
Naすなわち約90ミリ当量/lまでの投与を必要とす
る。K+の場合は、この濃度は18−42ミリ当量、特
に20−30、例えば25ミリ当量/lが好適である。The amount and type of carbohydrate source used is 30-90 g, preferably 50-7, per liter of liquid drink.
It is preferred to choose to provide 0 g, for example 60 g of carbohydrate / l. In addition to Na + and K + electrolytes,
The oral rehydration composition preferably contains a base to correct metabolic acidosis. Suitable bases for this purpose are bicarbonates, more suitably citrates, for example in the form of trisodium citrate dihydrate. The amounts of electrolyte and base to be added are preferably selected so that an appropriate concentration can be obtained when the solution is made into a drink. In the case of Na + , this concentration is preferably in the range of 30-90 milliequivalents per liter of drink liquid. Generally, low concentrations, eg 50-7
It is indicated to provide 0 meq / l, but in the case of diseases with a high degree of Na loss, such as cholera, high concentrations of Na, ie up to about 90 meq / l, are required. In the case of K + , this concentration is preferably 18-42 meq, especially 20-30, for example 25 meq / l.
【0007】損失を考慮したくえん酸塩の適当な濃度は
ドリンク1リットル当り25−30ミリ当量の範囲であ
る。塩素イオンの供給は、特にNaとグルコースの輸送
増加のためにNa吸収を確実にすることを考えた場合、
重要である。塩素イオンの適当な濃度は、30−90ミ
リ当量、例えば50ミリ当量/ドリンク液1リットルで
あり、Na+、K+および他のアニオンの総含量に応じて
変化する。ドリンク液は、120−360、例えば20
0−280キロカロリー、すなわち504−1512、
例えば840−1176KJを供給する量であるのが好
適である。Suitable citrate concentrations, taking into account losses, are in the range of 25-30 milliequivalents per liter of drink. Chloride supply, especially when considering ensuring Na uptake due to increased transport of Na and glucose,
is important. A suitable concentration of chloride ions is 30-90 meq, for example 50 meq / liter of drink liquor, depending on the total content of Na + , K + and other anions. The liquid drink is 120-360, for example 20.
0-280 kcal, or 504-1512,
For example, it is preferable that the amount is 840-1176 KJ.
【0008】適当な経口再水和製剤の例は下記の通りで
ある。 実施例1 製品100g当りの成分 マルトデキストリン* (DE25) 65.46g 前糊化米粉 13.40g 粉末形の凍結感想にんじん 13.00g くえん酸3ナトリウム2水和物 3.90g 塩化ナトリウム 2.50g 塩化カリウム 1.74g 経口再水和製剤 100.00g *:マルトデキストリン・エルシデックス(商標)DE1
2とマルトデキストリン・エルシデックス(商標)DE4
0の混合物 経口再水和製剤は、無機塩を混合し、粉砕し、粉砕物を
ふるいにかけ、残りの原料を加えて全体を混合すること
により製造し得る。Examples of suitable oral rehydration formulations are as follows: Example 1 Ingredients per 100 g of product Maltodextrin * (DE25) 65.46 g Pregelatinized rice flour 13.40 g Freezing impression in powder form Carrot 13.00 g Trisodium citrate dihydrate 3.90 g Sodium chloride 2.50 g Chloride chloride Potassium 1.74 g Oral rehydration formulation 100.00 g *: Maltodextrin Elsidex (trademark) DE1
2 and Maltodextrin Elsidex ™ DE4
Mixture of 0 Oral rehydrated formulations may be prepared by mixing the inorganic salts, crushing, sieving the crushed product, adding the remaining ingredients and mixing the whole.
【0009】実施例1の製品は、分析によると次の含量
を示す。The product of Example 1 shows the following contents by analysis.
【表1】 対象物 製品100g ドリンク液1リットル** 炭水化物 83.4g 80mM(61.0g) マルトデキストリン 63.3g 54mM グルコースポリマー: 米 10.7g 合わせて にんじん 9.4g 26mM 蛋白質(N×6.25) 2.5g 1.8g 脂質 0.3g 0.2g 電解質 ナトリウム 1.9g 60mEq カリウム 1.4g 25mEq 塩素 2.5g 50mEq くえん酸 2.4g 28mEq エネルギー Kcal 346 252 Kcal KJ 1446 1060 KJ 浸透圧モル濃度 m/0sm/l sol 250 浸透圧重量モル濃度 m/0sm/kgH20 263 **製品73.2gを含有。[Table 1] Target product 100 g Drink liquid 1 liter ** Carbohydrate 83.4 g 80 mM (61.0 g) Maltodextrin 63.3 g 54 mM Glucose polymer: Rice 10.7 g Combined carrot 9.4 g 26 mM Protein (N × 6. 25) 2.5g 1.8g Lipid 0.3g 0.2g Electrolyte Sodium 1.9g 60mEq Potassium 1.4g 25mEq Chlorine 2.5g 50mEq Citric Acid 2.4g 28mEq Energy Kcal 346 252 Kcal KJ 10 K Concentration 14K m / 0sm / l sol 250 Osmolality m / 0sm / kg H20 263 ** Contains 73.2g of product.
【0010】例えば強い熱、発熱、嘔吐により多量の液
体のそう失があった場合、希釈したドリンク液を投与し
得ることはいうまでもない。例えば、下痢の処置の場
合、実施例1の製品18.3gを水250ml(1びんの含
量)に溶解し得るが、脱水が著しい場合水500mlの溶
液として投与し得る。したがって、毎日投与する飲料の
量は特に液体そう失量によって変わる。Needless to say, a diluted drink solution may be administered when a large amount of liquid is lost due to intense heat, fever, or vomiting. For example, for the treatment of diarrhea, 18.3 g of the product of Example 1 can be dissolved in 250 ml of water (content of 1 bottle), but if dehydration is significant it can be administered as a solution in 500 ml of water. Therefore, the amount of beverage administered daily depends on, among other things, liquid loss.
【0011】以下の記載は、この発明の経口用再水和製
剤を乳児に用いる場合の適当な用法の指標となる。 第1段階 第1段階において脱水度を体重の減少により測定する。 脱水度 体重減少 軽度 5%以下 中度 6−9% 重度 10%以上 (ショック症状を伴なわない重度脱水の場合、経口再水
和が適応する。ショックがあれば再水和は静注によるべ
きである。) 第2段階 6時間の第1期間の間に、中度および重度の場合は乳児
に体重1kg当り表1のドリンク液100mlを4時間を要
して投与および/または体重1kg当り水50mlを2時間
を要して(または母親による緩やかな「随時」)投与する。
軽度脱水の場合、上記の半量を投与することができる。 第3段階 6時間後に、患者の状態を再評価する。再水和が充分正
常ならば、給食を開始し得る。再水和が不完全な場合、
第2段階の経口再水和をさらに6時間継続し得る。改善
がみられなければ、静脈注入再水和が指示される。この
処置および別の処置を、経口再水和ドリンク液による処
置のWHO推奨ガイドラインにしたがって行なう。The following description serves as an index for proper use when the oral rehydration preparation of the present invention is used for infants. Stage 1 In stage 1, dehydration is measured by weight loss. Dehydration Weight loss Mild 5% or less Moderate 6-9% Severe 10% or more (For severe dehydration without shock symptoms, oral rehydration is indicated. If shock occurs, rehydration should be intravenous injection. 2nd stage During the first period of 6 hours, 100 ml of the liquid drink of Table 1 per 1 kg of body weight is administered to infants in moderate and severe cases over 4 hours and / or water per 1 kg of body weight. Administer 50 ml over 2 hours (or gently "on occasion" by the mother).
For mild dehydration, half of the above can be administered. Phase 3 Six hours later, reassess patient status. If rehydration is normal enough, feeding may begin. If rehydration is incomplete,
The second stage oral rehydration may continue for a further 6 hours. If no improvement is noted, intravenous rehydration is indicated. This and other procedures are performed according to the WHO recommended guidelines for treatment with oral rehydrated drinks.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 モンセラット・バンケ・モラス スペイン08010バルセロナ、ブルク42−44 番 2/2 ─────────────────────────────────────────────────── ─── Continued Front Page (72) Inventor Montserrat Banque Moras Spain 08010 Barcelona, Burg 42-44 2/2
Claims (17)
る上記電解質と共に、炭水化物源として慣用炭水化物に
加えて米粉およびにんじんの粉を含む、経口投与用の調
剤した再水和組成物。1. A formulated rehydrated composition for oral administration comprising rice flour and carrot flour in addition to conventional carbohydrates as a carbohydrate source, together with said electrolytes to compensate for the loss of Na + and K + electrolytes.
組成物。2. The composition of claim 1, wherein the rice flour is in pregelatinized form.
1または2記載の組成物。3. The composition according to claim 1, wherein the carrot is in a freeze-dried powder form.
の範囲内にある、請求項1−3の何れか1項記載の組成
物。4. The weight ratio of rice flour: carrot is 5: 1 to 1: 5.
The composition according to any one of claims 1 to 3, which is within the range.
である、請求項1−4の何れか1項記載の組成物。5. A composition according to any one of claims 1-4, wherein the conventional carbohydrate material is a glucose polymer.
用炭水化物材料の重量比が1:1−1:7の範囲内にあ
る、請求項1−5の何れか1項記載の組成物。6. A composition according to any one of claims 1-5, wherein the weight ratio of rice flour derived carbohydrate and carrot: conventional carbohydrate material is in the range of 1: 1-1: 7.
に足る量の塩基を含む、請求項1−6の何れか1項記載
の組成物。7. The composition according to claim 1, further comprising a base in an amount sufficient to correct metabolic acidosis.
の組成物。8. The composition according to claim 7, wherein the base is a citrate.
項記載の組成物。9. The method according to claim 1, which is in a powder form.
The composition according to the item.
れか1項記載の組成物。10. The composition according to claim 1, which is in a drink form.
512KJを供給する量の炭水化物を含む、請求項10
記載の組成物。11. 504-1 per liter of drink liquid
11. Containing an amount of carbohydrates to provide 512 KJ.
The composition as described.
ミリ当量のNaイオンを含む、請求項10または11記
載の組成物。12. 30-90 per liter of drink liquid
The composition according to claim 10 or 11, which comprises milliequivalents of Na ions.
ミリ当量のKイオンを含む、請求項1−12の何れか1
項記載の組成物。13. 18-42 per liter of drink liquid
13. Any one of claims 1-12 comprising milliequivalent K ions.
The composition according to the item.
ミリ当量のシトラートを含む、請求項10−13の何れ
か1項記載の組成物。14. 25-35 per liter of drink liquid
The composition according to any one of claims 10 to 13, which comprises milliequivalents of citrate.
ミリ当量の塩素イオンを含む、請求項10−14の何れ
か1項記載の組成物。15. 30-90 per liter of drink liquid
The composition according to any one of claims 10 to 14, which comprises milliequivalent chlorine ions.
オスモル未満の浸透圧重量モル濃度を有する、請求項1
0−15の何れか1項記載の組成物。16. An osmolality of less than 300 milliosmoles per liter of drink liquor.
The composition according to any one of 0 to 15.
gの炭水化物を供給する、請求項10−16の何れか1
項記載の組成物。17. 30-90 per liter of drink liquid
17. Any one of claims 10-16, which supplies g of carbohydrates.
The composition according to the item.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4065824A JPH05286863A (en) | 1992-03-24 | 1992-03-24 | Improvement of organic compound |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4065824A JPH05286863A (en) | 1992-03-24 | 1992-03-24 | Improvement of organic compound |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH05286863A true JPH05286863A (en) | 1993-11-02 |
Family
ID=13298166
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP4065824A Pending JPH05286863A (en) | 1992-03-24 | 1992-03-24 | Improvement of organic compound |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH05286863A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5576001A (en) * | 1995-02-22 | 1996-11-19 | Abu-Shaaban; Medhat | Composition for the treatment of diarrhea, its use and its preparation |
WO1996037206A1 (en) * | 1995-05-26 | 1996-11-28 | Virbac Laboratories (Nz) Limited | Rice flour based oral rehydration compositions for farm animals |
JP2008178400A (en) * | 2006-12-27 | 2008-08-07 | Kao Corp | Container drink |
-
1992
- 1992-03-24 JP JP4065824A patent/JPH05286863A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5576001A (en) * | 1995-02-22 | 1996-11-19 | Abu-Shaaban; Medhat | Composition for the treatment of diarrhea, its use and its preparation |
WO1996037206A1 (en) * | 1995-05-26 | 1996-11-28 | Virbac Laboratories (Nz) Limited | Rice flour based oral rehydration compositions for farm animals |
JP2008178400A (en) * | 2006-12-27 | 2008-08-07 | Kao Corp | Container drink |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2373473C (en) | Electrolyte gels for maintaining hydration and rehydration | |
US10596135B2 (en) | Method, composition and package for bowel cleansing | |
US4942042A (en) | Anti-diarrhea compositions | |
EP2292244B1 (en) | Salt Solution for Colon Cleansing | |
Lifshitz et al. | Oral hydration solutions: experimental optimization of water and sodium absorption | |
US5869459A (en) | Frozen rehydration formulation and delivery system therefor | |
JPH09183732A (en) | Potassium dominant non-solution pill and health promotion using the pill | |
US5498408A (en) | Oral rehydration composition | |
JPH05286863A (en) | Improvement of organic compound | |
JPH04287660A (en) | Prophylactic composition against fluorosis and method for prevention thereof | |
Meyers | Fluid and electrolyte therapy for children | |
Klish | Use of oral fluids in treatment of diarrhea | |
Walan et al. | Metabolic consequences of reduced gastric acidity | |
Atakent et al. | The adverse effects of high oral osmolal mixtures in neonates: a review and a study of the osmolality of calcium preparations | |
US20220312813A1 (en) | Formulation for iron supplements | |
SANFORD et al. | Round table discussion: the premature infant | |
Cook | FROM THE MANAGEMENT | |
JP2005508984A (en) | Rehydrating preparation | |
AU2002225823A1 (en) | Method for treating HIV | |
Mahalanabis | Oral Rehydration Therapy | |
BE631153A (en) |